Safety Study of Atomoxetine and Cerebrovascular Outcomes

Clinical trial NCT00634439 · COMPLETED

Trial details

NCT number: NCT00634439
Sponsor: Eli Lilly and Company
Status: COMPLETED
Study type: OBSERVATIONAL

Cerebrovascular Accident Transient Ischemic Attack ADHD

Start date: 2008-01-01
Primary completion: 2008-09-01
Enrollment: 72000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.